Entasis Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
August 06 2019 - 8:00AM
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage
biopharmaceutical company focused on the discovery and development
of novel antibacterial products, today announced that Dr. Manos
Perros, President and Chief Executive Officer of the Company, will
present at the 2019 Wedbush PacGrow Healthcare Conference being
held August 13-14, 2019 in New York.
Details of the presentation are below:
Event: |
Wedbush PacGrow Healthcare Conference |
Date: |
Tuesday, August 13, 2019 |
Location: |
The Parker New York Hotel |
Time: |
9:45 – 10:15 AM ET |
Additionally, Dr. Perros will hold 1-on-1
investor meetings at the conference. Investors attending the
conference who are interested in meeting with Company management
should contact their Wedbush representatives.
About EntasisEntasis is a
clinical-stage biopharmaceutical company focused on the discovery,
development and commercialization of novel antibacterial products
to treat serious infections caused by multidrug-resistant
Gram-negative bacteria. Entasis’ pathogen-targeted design platform
has produced a pipeline of product candidates, including
sulbactam-durlobactam (targeting Acinetobacter
baumannii infections), zoliflodacin (targeting Neisseria
gonorrhoeae), and ETX0282CPDP
(targeting Enterobacteriaceae infections). Entasis is
also using its platform to develop a novel class of antibiotics,
non-β-lactam inhibitors of the penicillin-binding proteins (NBPs)
(targeting Gram-negative infections). For more information,
visit www.entasistx.com.
Entasis Company ContactKyle Dow Entasis
Therapeutics (781) 810-0114 kyle.dow@entasistx.com
Investor Relations Contacts Tram Bui / Janhavi
Mohite The Ruth Group (646) 536-7035 / 7026 tbui@theruthgroup.com
jmohite@theruthgroup.com
Media ContactKirsten ThomasThe Ruth Group(508)
280-6592kthomas@theruthgroup.com
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Entasis Therapeutics (NASDAQ:ETTX)
Historical Stock Chart
From Sep 2023 to Sep 2024